With the stock currently trading at Rs 405.05, Biocon has demonstrated strong financial performance and positive investor sentiment, as reflected by its 52-week high and bullish market outlook.

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

In June 2025, mutual funds made aggressive portfolio shifts, with major buying concentrated in stocks like Asian Paints, Dixon Technologies, and Vishal Mega Mart, ...

So far in 2025, a total of 30 companies have raised nearly Rs 60,000 crore via QIPs, building on the strong momentum from ...

The Nifty Pharma index was down 0.59 per cent at 22545.95 at the time of writing this report. Benchmark NSE Nifty50 index was ...

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

As per the Global Entrepreneurship Monitor, presently, there are more than 658 million active female founders and business ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

RRP Defense Limited, has entered into a Letter of Intent with CYGR, a Franco-American and drone technology company, a leading ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by the increasing demand for outsourced drug discovery activities, advancements ...

The global healthcare landscape is in a constant state of evolution, driven by technological breakthroughs, demographic ...

Forbes’ 2025 list ranks Nykaa’s Falguni Nayar and Biocon’s Kiran Mazumdar-Shaw among the 50 wealthiest self-made women in the ...